Prostate Cancer

ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. May 24, 2022

Is ultra-hypo-fractionated radiotherapy more cost-effective relative to conventional fractionation in treatment of prostate cancer? A cost-utility analysis alongside a randomized HYPO-RT-PC trial. May 24, 2022

The growing role of rucaparib in contemporary treatment of metastatic prostate cancer: a review of efficacy and guidance for side effect management. May 24, 2022

Morbidity of salvage radical prostatectomy: limited impact of the minimally invasive approach. May 23, 2022

Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis. May 23, 2022

Racial and Ethnic Differences in Rural-Urban Trends in 5-Year Survival of Patients With Lung, Prostate, Breast, and Colorectal Cancers: 1975-2011 Surveillance, Epidemiology, and End Results (SEER). May 23, 2022

Plain language summary of the HERO study comparing relugolix with leuprolide for men with advanced prostate cancer. May 23, 2022

Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological Consortium. May 23, 2022

Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation-A Multicenter Validation Study. May 20, 2022

Mobile Clinical Trial Matching Technology in Medical Oncology Clinic: A Pilot Feasibility Study. May 20, 2022

Nationwide Industry-Led Community Exercise Program for Men With Locally Advanced, Relapsed, or Metastatic Prostate Cancer on Androgen-Deprivation Therapy. May 20, 2022

Penalized weighted proportional hazards model for robust variable selection and outlier detection. May 20, 2022

Quality of life in low-income men after surgical castration for metastatic prostate cancer. May 20, 2022

Embracing the Practical Aspects of Theranostics With Prostate-Specific Membrane Antigen–Targeted Lutetium-177 May 19, 2022

Pre-operative magnetic resonance imaging can predict prostate cancer with risk for positive surgical margins. May 19, 2022

Factors that guide selection among androgen receptor inhibitors in patients with nonmetastatic castration-resistant prostate cancer. May 19, 2022

Audit of cancer yields after prostate MRI using both the PI-RADS version 2 and Likert scoring systems. May 19, 2022

Circulating free testosterone and risk of aggressive prostate cancer: prospective and Mendelian randomization analyses in international consortia. May 19, 2022

Evaluating post radical prostatectomy mechanisms of early continence. May 19, 2022

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality. May 18, 2022

Page 1 of 1224

email news signup